Skip to content 
Peptide purity and peptide identity are related but separate analytical attributes. This article explains how laboratories evaluate each one, why both belong on a serious COA review, and what research buyers should look for in RUO peptide documentation.
Peptide purity testing is more than a single percentage on a label. This article explains how HPLC, LC-MS, assay, impurity profiling, and batch-specific COA review fit together in research-use-only peptide evaluation.
LC-MS testing for peptide identity helps laboratories confirm whether a peptide batch aligns with its expected mass-based and sequence-supporting profile. This article explains what the method measures, where it fits in COA review, and why orthogonal methods still matter for RUO peptide sourcing.
This article explains what HPLC testing for research peptides actually measures, what it cannot prove on its own, and how laboratory buyers should evaluate chromatograms and COA documentation. It is written for research-use-only sourcing and documentation review.
GLP-1, GIP, and glucagon pathway research overlap at the receptor-family level but diverge in signaling context, liver emphasis, and assay interpretation. This RUO-safe guide explains what researchers compare, which readouts matter, and why documentation belongs in the workflow.
Freeze-thaw events can alter peptide aggregation, recovery, and measured assay values, but the effect is peptide- and matrix-specific. This RUO-focused guide explains the mechanisms, evidence base, and documentation standards researchers should review before selecting peptide materials.
This article explains how cellular pathway peptides are studied in laboratory settings, from receptor and intracellular signaling mechanisms to LC-MS, HPLC, and COA review. It is written for RUO procurement, assay planning, and evidence-based interpretation.
Discount Applied Successfully!
Your savings have been added to the cart.
